Tusup M - Search Results

1

Tusup M, Kundig T, Pascolo S. Tusup M, et al. World J Clin Oncol. 2018 Jun 10;9(3):42-55. doi: 10.5306/wjco.v9.i3.42. World J Clin Oncol. 2018. PMID: 29900123 Free PMC article. Review.

2

Generation of Immunostimulating 130 nm Protamine-RNA nanoparticles.

Tusup M, Pascolo S. Tusup M, et al. Methods Mol Biol. 2017;1499:155-163. doi: 10.1007/978-1-4939-6481-9_9. Methods Mol Biol. 2017. PMID: 27987148

3

Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer.

Samaras P, Tusup M, Nguyen-Kim TDL, Seifert B, Bachmann H, von Moos R, Knuth A, Pascolo S. Samaras P, et al. Among authors: tusup m. Cancer Chemother Pharmacol. 2017 Nov;80(5):1005-1012. doi: 10.1007/s00280-017-3446-y. Epub 2017 Oct 4. Cancer Chemother Pharmacol. 2017. PMID: 28980060 Clinical Trial.

4

Charting DENR-dependent translation reinitiation uncovers predictive uORF features and links to circadian timekeeping via Clock.

Castelo-Szekely V, De Matos M, Tusup M, Pascolo S, Ule J, Gatfield D. Castelo-Szekely V, et al. Among authors: tusup m. Nucleic Acids Res. 2019 Jun 4;47(10):5193-5209. doi: 10.1093/nar/gkz261. Nucleic Acids Res. 2019. PMID: 30982898 Free PMC article.

5

Design of in vitro Transcribed mRNA Vectors for Research and Therapy.

Tusup M, French LE, De Matos M, Gatfield D, Kundig T, Pascolo S. Tusup M, et al. Chimia (Aarau). 2019 May 29;73(5):391-394. doi: 10.2533/chimia.2019.391. Chimia (Aarau). 2019. PMID: 31118121 Free article. Review.

6

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma.

Tusup M, Cheng PF, Picardi E, Raziunaite A, Dummer R, Levesque MP, French LE, Guenova E, Kundig TM, Pascolo S. Tusup M, et al. Noncoding RNA. 2021 Jan 12;7(1):5. doi: 10.3390/ncrna7010005. Noncoding RNA. 2021. PMID: 33445472 Free PMC article.

7

mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma.

Tusup M, Läuchli S, Jarzebska NT, French LE, Chang YT, Vonow-Eisenring M, Su A, Kündig TM, Guenova E, Pascolo S. Tusup M, et al. Pharmaceutics. 2021 Jul 7;13(7):1040. doi: 10.3390/pharmaceutics13071040. Pharmaceutics. 2021. PMID: 34371731 Free PMC article.

8

Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors.

Tusup M, Kündig TM, Pascolo S. Tusup M, et al. Mol Ther. 2022 Mar 2;30(3):1163-1170. doi: 10.1016/j.ymthe.2021.09.022. Epub 2021 Sep 24. Mol Ther. 2022. PMID: 34563676 Free PMC article.

9

The A to I editing landscape in melanoma and its relation to clinical outcome.

Amweg A, Tusup M, Cheng P, Picardi E, Dummer R, Levesque MP, French LE, Guenova E, Läuchli S, Kundig T, Mellett M, Pascolo S. Amweg A, et al. Among authors: tusup m. RNA Biol. 2022 Jan;19(1):996-1006. doi: 10.1080/15476286.2022.2110390. RNA Biol. 2022. PMID: 35993275 Free PMC article.

10

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5.

Tusup M, Cheng PF, Picardi E, Raziunaite A, Dummer R, Levesque MP, French LE, Guenova E, Kundig TM, Pascolo S. Tusup M, et al. Noncoding RNA. 2022 Nov 21;8(6):79. doi: 10.3390/ncrna8060079. Noncoding RNA. 2022. PMID: 36412914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page